Eyestem raises $6.4M in Series A round

The investment will allow Eyestem to progress a treatment for Dry Age-related Macular Degeneration into clinical trials.

Eyestem, a Bengaluru-based cell therapy company, has raised $6.4 million (Rs 51 crore) in a Series A round led by three pharma majors: Biological E Limited (BE), Alkem, NATCO, and Kemwell Biopharma promoters Anurag and Karan Bagaria.

Endiya Partners and Kotak Private Equity, both existing investors, also participated in this round, valuing Eyestem at $46.4 million (Rs 371 crore) post-money.

"We started Eyestem with the sole purpose of being able to create cell therapy products at scale for diseases that devastate a large number of people in India and around the world," said Dr. Jogin Desai, Founder and CEO of Eyestem. The backing of major Indian pharmaceutical companies who share our vision validates our strategy of developing affordable innovation for patients all over the world. Following this funding, we will continue to focus on solidifying our cell therapy platform and advancing our flagship product for Dry AMD through international standard early clinical trials."

Eyecyte-RPE, the company’s patented flagship product, is an experimental treatment for Dry Age-related Macular Degeneration (Dry AMD) and the company has other products in the pipeline for the treatment of incurable diseases affecting humanity. EyeCyte-RPE replaces damaged retinal pigment epithelium cells and is designed to restore sight for patients in early stages of Macular Degeneration or arrest loss of vision for those in later stages. The product is allogenic, administered by a surgical procedure and is patented in India and abroad. The company intends to file for a first in human trial for the product within a year in consultation with CDSCO and US FDA. 

"We are very happy to be associated with Eyestem for its innovative work that services unmet needs of patients that have a high impact on quality of life," said Rajeev Nannapaneni, CEO of NATCO Pharma Limited.

"Endiya Partners is delighted to back such strong, globally competitive innovative startups and participate in the current funding round," said Dr Ramesh Byrapaneni, Managing Partner of Endiya Partners. The addition of leading pharma and biotech investors to our capitalization table is a great validation of the world-class science that Eyestem is pursuing, which has the potential to change millions of lives around the world."

Eyestem was founded in 2016 by an experienced team of clinical research, regenerative medicine, and ophthalmology experts. It is advised by a board of directors and has established collaborations with other leaders in related scientific disciplines in India, the United Kingdom, Japan, and the United States. Long-term goals include developing a scalable cell therapy platform to treat incurable diseases and democratizing global access to these newer technologies.

Tags : #Eyestem #funding #seriesaAround #fundingalert #DryAge-relatedMacularDegeneration #clinicaltrials #banglore #india #pharma #natco #medicircle #smiitakumar

About the Author


Shweta Yadav

I strive to provide you with the most current and up-to-date healthcare news and articles in all main areas. Within the Medicircle umbrella, a wide range of themes and categories concerning health.

Related Stories

Loading Please wait...

-Advertisements-



Trending Now

Actor-Director Sathish Kaushik Died of a Heart Attack at the Age of 66March 09, 2023
Soleus Push-Ups: A Laziest Exercise to Lower Blood Sugar LevelsMarch 09, 2023
World Kidney Day 2023: Be Aware of Kidney DiseasesMarch 09, 2023
Sushmita Sen reveals about suffering from a severe heart attack recently and Addison's disease in 2014March 06, 2023
A significant increase in influenza A H3N2 patients that are accompanied by severe coughing and feverMarch 06, 2023
Is AIDS or HIV curable in Ayurveda?March 03, 2023
Artificial Sweetener Erythritol Raises the Possibility of Heart Attack.March 01, 2023
Difference between HIV and AIDS - When to give antiretroviral therapy?March 01, 2023
Zero Discrimination Day: Let's Raise the Voice Against DiscriminationMarch 01, 2023
International Women’s Day 2023 – Embrace EquityFebruary 28, 2023
Brain Tumors - Types, Symptoms and Risk FactorsFebruary 28, 2023
World Rare Disease Day: End Stigma Against Rare Diseases.February 28, 2023
National Science Day 2023 - Global Science for Global WellbeingFebruary 28, 2023
Eating disorders - Types and their complicationsFebruary 27, 2023
The condition that took away the life of Malayalam filmmaker, Joseph ManuFebruary 27, 2023
World NGO Day 2023 - We make a living by what we get, but we make a life by what we giveFebruary 27, 2023
Functions and Problems of SerotoninFebruary 25, 2023
Arthritis management – Tips to manage arthritis effectivelyFebruary 25, 2023
Apple has undertaken a project of no-prick blood sugar monitoring feature for its watch.February 24, 2023
Bird flu – Jharkhand on alert, know its prevention and symptoms in humansFebruary 24, 2023